“…miR-34a targets E2F3, Numbl, platelet-derived growth factor receptor A (PDGFRA), synaptotagmin 1 (Syt1), autophagy-related 9a (Atg9a), CD44, cyclic AMP response-element binding protein (CREB), brain-derived neurotrophic factor (BDNF) to inhibit cell proliferation, migration, invasion and adhesion [ 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 ]. It regulates extracellular signal-regulated kinase 1/2 (ERK) and p38, and increases nuclear factor kappa light chain enhancer of activated B cells (NF-κB), Sirtuin 1 (SIRT1) and Bcl2, to promote or reduce apoptosis [ 66 , 67 , 68 ].…”